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Introduction 
 
Myofibroblasts, or also known as activated fibroblasts, are dynamic, 
spindle-like cells sharing the functional characteristics of both 
fibrocytes and smooth muscle cells. They actively migrate and 
proliferate in the subepithelial matrix, secrete extracellular matrix 
proteins and promote wound healing. Myofibroblasts are found in low 
density in healthy tissue but are abundant in wounded tissue. As the 
unspecific inflammatory response advances in wounded tissue, 
different mixtures of bioactive compounds (such as growth factors, 
cytokines, chemokines and cyclo-oxygenase products) are released by 
the injured mucosa, endothelial cells and even by the fibroblasts 
causing a regulatory cascade and transformation of the resident 
fibrocytes into myofibroblasts.  
Under pathophysiological conditions, in case of a permanent noxa the 
normal remodelling process is damaged. Chronic gastritis due to 
Helicobacter pylori infection has been extensively studied in recent 
decades and the connection between the pathogen and gastric cancer is 
now proven. Most investigations focused their research on epithelial 
cells and little is known about the connective tissue cells in tumors, 
though they are important in tumor expansion. In gastric cancer, the 
tumor stroma can make up to 80% of the whole tumor mass and the 
dominating cell type within is the fibroblast.  
Myofibroblasts take part in the chronic inflammation-adenoma-
carcinoma sequence by altering the microenvironment around 
epithelial cells. In the tumor, the boosted metabolic pathways generate 
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lots of acidic metabolites which are exported from the cells via 
various plasma membrane transporters. As upregulated ion 
transporters excrete the excess protons from the cells, the cytoplasm 
becomes more alkaline, while the environment becomes more acidic. 
In recent years this phenomenon became a hallmark of cancer and 
provided the researchers a new, thermodynamic approach to cancer 
research. Many authors have investigated the regulation of acid/base 
transporters and their role in migration and proliferation. Generally, 
they found that certain transporters are implicated in upregulated 
migration and proliferation of sancer cells. Acid/base transporters are 
well characterized in gastric epithelial cells, but there is scarce 
information about the transporters of gastric myofibroblasts which 
surround malignant cells. The alterations in the epithelial 
microenvironment in the evolution of cancer are poorly understood, 
yet they are of great importance. Data indicate that myofibroblasts 
may be the pioneer cells at the site of distant invasion, called niche, 
thus aiding malignant cells in forming metastases. Cancer-associated 
myofibroblasts (CAMs), a sub-class of myofibroblasts, are important 
stromal cells with distinct properties and  recent  work  indicates  that 
differences in  gene  expression  in  the  stromal  compartment  predict  
clinical outcome  and  response  to  therapy. The changes on 
epigenetic level have also been detected in CAMs from gastric cancer 
compared with myofibroblasts derived from normal tissue 
myofibroblasts. We also know that TGF-β1 levels in the tumor mass 
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and myofibroblast numbers correlate with worse survival of gastric 
cancer.  
 
Aims 
 
Our primary objective was to characterize the acid/base transporters of 
cultured human gastric myofibroblasts and to search for a connection 
to cell function.  
 
Materials and methods 
 
The study was approved by the Ethics Committee of the University of 
Szeged, Hungary (study number 12/2006). All patients gave infomed 
consent. Gastric tissue specimens were collected intra-operatively 
from patients who underwent gastric tumor resection or from multiple 
organ cadaver donors.  
Then specimens were cultured to establish monolayer myofibroblast 
cultures and they also were analyzed histologically. The cultures were 
stained for myofibroblast markers with immunocytochemistry.  
The resting pHi, basic acid/base characteristics, the buffering capacity 
and the acid/base transporters of the human gastric myofibroblasts 
(HGMs) were then investigated with microfluorometry using pH-
sensitive dye and a specific sodium/hydrogen exchanger (NHE) 
inhibitor.  
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We used RT-PCR, immunocytochemistry and immunoblot analysis to 
show isoforms of NHE.  
Migration and proliferation assays were utilized to examine the 
connection between NHE activity and migration-proliferation of 
HGMs.  
Statistical analyses (Students’ t-test or ANOVA) were applied to test 
significance of results. Results were considered significant at  p<0.05. 
 
Results 
Morphology of the myofibroblasts and purity of HGM cultures 
 
We histologically processed the same gastric samples from which we 
took of our specimens to investigate myofibroblast morphology. We 
showed increased number of myofibroblasts, disordered cell 
morphology and damaged cyto-architecture in the samples from 
gastric cancer compared to the normal tissue. We also showed that the 
purity of our HGM cultures was ~100%. 
 
Investigation of acid/base transporters with microfluorometry 
 
 
Our experiments showed that the resting pHi of HGMs in standard 
HEPES solution was 7.09 ± 0.02.  
We found using ion withdrawal techniques that an active Na+-
dependent H+-efflux mechanism is present in HGMs indicating the 
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presence of NHEs. In HCO3- /CO2-containing solutions, we showed 
certain pH regulating mechanisms indicating the presences of the 
Na+/HCO3- cotransporter (NBC) and the anion exchanger (AE). The 
above findings were confirmed by using the ammonium pulse 
technique. We also determinded the buffering capacity of HGMs. Our 
data suggest that NHE and NBC are very active in HGMs.  
Next we focused on NHEs and charcterized the functional acitivities 
of NHE isoforms using selective NHE inhibitor HOE-642. Our data 
indicate that NHE1 is responsible for about 85% of the Na+/H+ 
exchange activity, whereas NHE2 activity is around 10 % and the 
remaining NHE activity is approximately 5 %.  
Then we investigated the effects of insulin-like growth factor II (IGF-
II) and carbachol on the activities of NHEs. Importantly, both IGF-II 
and carbachol dose-dependently stimulated NHE activity. 10 µM 
carbachol had the greatest effect on NHE activity (two-fold increase). 
100 ng/ml IGF-II was more effective (one and a half-fold increase) 
than 10 ng/ml in increasing NHE activity.  
 
mRNA and protein expression of NHE1-3 
 
Based on the results of the functional measurements, we investigated 
the presence of NHE transporters at the mRNA and protein levels. 
RT-PCR confirmed the expression of NHE1, NHE2 and NHE3. We 
also analysed the expression of NHE isoforms in HGMs by Western 
blot. We found that NHE1 is present in HGMs, but we were unable to 
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show NHE2 and NHE3 expression. Using immunocytochemistry, we 
demonstrated NHE1-3 localization to the plasma membrane of HGMs. 
 
IGF-II increases proliferation in an NHE1-dependent manner 
 
Finally, we tested the effects of HOE-642, IGF-II and carbachol on 
HGM proliferation. Ethynyl deoxy uridine incorporation assays 
showed that 100 ng/ml IGF-II increased cell proliferation over two-
fold. Carbachol and/or HOE-642 did not affect proliferation. 
However, NHE1 inhibition by 1 µM HOE-642 completely blocked the 
stimulatory effect of IGF-II on cell proliferation. 
 
TGFβig-h3 restrains tumor growth in vivo  
 
We showed in our parallel work (article related to the subject of the 
thesis II.) that proliferation of gastric myofibroblasts is even more 
stimulated by IGF-II from sepcimens of gastric cancer (CAMs). Those 
data demostrate that the proteome and secretome of normal 
myofibroblasts and CAMs are different by Metacore analyses. The 
differences are exaggerated in CAMs from patients with short 
survival. Dominant changes are mostly at the level of ECM 
(extracellular matrix) proteins, cytoskeletal re-arrengement and actin 
filaments.  
By focusing on CAM secretomes, we have identified an unexpected 
role for myofibroblasts in restraining tumor migration and 
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proliferation in early disease through secretion of a certain ECM 
molecule, TGFβig-h3, which not only inhibits proliferation and 
migration of myofibroblasts and gastric cancer cells, but also restrains 
tumor growth in vivo in xenograft experiments.  
This molecule is down-regulated in CAMs enabling more aggresive 
expansion and better response to IGF-II. We demonstrate, that 
TGFβig-h3 expression is greatly decreased in CAMs originating from 
patients with poor survival.  
Depression of TGFβig-h3 secretion by myofibroblasts occurs with 
tumor progression and could provide a novel functional biomarker for 
stromal cell properties in cancer. Moreover, it may also be possible to 
develop novel therapeutic strategies based on the observation that 
stromal cell-stimulated tumor growth in vivo is prevented by 
restoration of TGFβig-h3. 
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Summary and new findings 
 
 
Myofibroblasts play central roles in wound healing, deposition of the 
extracellular matrix and - via extensive neurohumoral communication 
- in the epithelial function and cancer development as well. Their 
functions depend on migration and proliferation within the 
subepithelial matrix, which results in boosted cellular metabolism. 
Upregulated metabolic pathways generate acidic metabolites which 
need to be excreted to maintain intracellular pH (pHi). It has been 
reported that acid/base transporters have a great impact on cell 
function and they also may have specific contributions to cancer 
development.  
We isolated human gastric myofibroblasts (HGMs) from surgical 
specimens of 5 patients. Our data show that HGMs originating from 
gastric cancer are greatly increased in number, their morphology is 
distorted and the architecture is damaged compared to those 
originating from nomal tissue. Then we characterized, for the first 
time, the expression and functional activities of the Na+/H+ exchanger 
(NHE) isoforms 1, 2 and 3, and the functional activities of the 
Na+/HCO3- cotransporter (NBC) and the anion exchanger (AE) in 
cultured HMGs using microfluorimetry, immunocytochemistry, RT-
PCR and immunoblot analysis.  
We showed that NHE1-3, NBC and AE activities are present in 
HMGs and that NHE1 is the most active of the NHEs. In scratch 
wound assays we also demonstrated (using the selective NHE 
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inhibitor HOE-642) that carbachol and IGF-II partly stimulate 
migration of HMGs in a NHE1-dependent manner. EdU incorporation 
assays revealed that IGF-II induces proliferation of HMGs which is 
inhibited by HOE-642.  
The results indicate that NHE1 is necessary for IGF-II-induced 
proliferation response of HMGs. Overall, we have characterized the 
pHi regulatory mechanisms of HGMs. In addition, we demonstrated 
that NHE1 activity contributes to both IGF-II- and carbachol-
stimulated migration and that it is obligatory for IGF-II-induced 
proliferation of HGMs 
Additionally, we demonstrated in our parallel work, that HGMs 
secrete TGFβig-h3 that restrains tumor growth in vivo and this 
function is damaged in CAMs.  
Our results contribute to the better understanding of the epithelial and 
tumor microenvironment and may have further significance in the 
future of targeted cancer therapy.  
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